NCT04238975View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3111 in Healthy Adults

PHASE2UnknownINTERVENTIONAL
Enrollment

213

Participants

Timeline

Start Date

October 14, 2019

Primary Completion Date

February 28, 2021

Study Completion Date

May 31, 2021

Conditions
TetanusDiphtheriaWhooping Cough
Interventions
BIOLOGICAL

GC3111 vaccine

0.5mL, Intramuscular

BIOLOGICAL

Boostrix® vaccine

0.5mL, Intramuscular

Trial Locations (1)

Unknown

RECRUITING

The Catholic Univ. of Korea Eunpyeong St. Mary's Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Green Cross Corporation

INDUSTRY